We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+5.28%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.14B
AUM Growth
+$467M
(+10%)
Cap. Flow
+$273M
Cap. Flow
% of AUM
5.31%
Top 10 Holdings %
Top 10 Hldgs %
11.46%
Holding
1,074
New
159
Increased
412
Reduced
333
Closed
136
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$28.6M |
| 2 |
AGN
Allergan plc
AGN
|
+$26.5M |
| 3 |
Toro Company
TTC
|
+$22.4M |
| 4 |
PepsiCo
PEP
|
+$20.4M |
| 5 |
Lockheed Martin
LMT
|
+$17.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$26.1M |
| 2 |
Wells Fargo
WFC
|
+$19.4M |
| 3 |
Centene
CNC
|
+$17.3M |
| 4 |
Eli Lilly
LLY
|
+$15.8M |
| 5 |
Kroger
KR
|
+$14.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Financials | 18.08% |
| 3 | Industrials | 12.96% |
| 4 | Healthcare | 11.05% |
| 5 | Consumer Discretionary | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Medifast
MED
$108M
| $364K | 0.01% |
+6,130
| New | +$305K |
|
752
Paylocity
PCTY
$6.71B
| $364K | 0.01% |
+7,460
| New | +$346K |
|
|
VRE
753
DELISTED
Veris Residential
VRE
| $364K | 0.01% |
+15,360
| New | +$378K |
|
754
Asbury Automotive
ABG
$4.19B
| $363K | 0.01% |
5,940
-8,130
| -58% | -$449K |
|
755
International Flavors & Fragrances
IFF
$19.4B
| $363K | 0.01% |
2,540
| – | – |
|
|
FNHC
756
DELISTED
FedNat Holding Company Common Stock
FNHC
| $361K | 0.01% |
23,100
-2,600
| -10% | -$39.4K |
|
|
TGH
757
DELISTED
Textainer Group Holdings limited
TGH
| $360K | 0.01% |
21,000
-43,910
| -68% | -$700K |
|
|
LTS
758
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $360K | 0.01% |
125,087
+22,970
| +22% | +$57.2K |
|
|
TPIC
759
DELISTED
TPI Composites
TPIC
| $359K | 0.01% |
+16,080
| New | +$321K |
|
760
Procter & Gamble
PG
$343B
| $356K | 0.01% |
3,912
-3,050
| -44% | -$278K |
|
761
Perrigo
PRGO
$1.4B
| $356K | 0.01% |
+4,200
| New | +$327K |
|
762
Marchex
MCHX
$79.7M
| $348K | 0.01% |
112,729
-6,200
| -5% | -$18.5K |
|
763
Best Buy
BBY
$18B
| $347K | 0.01% |
6,100
-630
| -9% | -$36.1K |
|
764
Global Industrial
GIC
$1.34B
| $346K | 0.01% |
+13,080
| New | +$297K |
|
|
NBL
765
DELISTED
Noble Energy, Inc.
NBL
| $345K | 0.01% |
12,180
-37,888
| -76% | -$998K |
|
766
Grand Canyon Education
LOPE
$3.71B
| $344K | 0.01% |
3,790
-270
| -7% | -$21.6K |
|
767
Axcelis
ACLS
$4.12B
| $340K | 0.01% |
+12,420
| New | +$275K |
|
768
FB Financial Corp
FBK
$2.95B
| $340K | 0.01% |
+9,020
| New | +$315K |
|
769
QuinStreet
QNST
$870M
| $338K | 0.01% |
46,050
+18,426
| +67% | +$89.3K |
|
|
ADVM
770
DELISTED
Adverum Biotechnologies
ADVM
| $335K | 0.01% |
9,169
+970
| +12% | +$26.9K |
|
771
Johnson Outdoors
JOUT
$482M
| $333K | 0.01% |
+4,548
| New | +$265K |
|
772
Celldex Therapeutics
CLDX
$2.77B
| $332K | 0.01% |
7,747
+1,967
| +34% | +$73.7K |
|
773
Warrior Met Coal
HCC
$4.23B
| $332K | 0.01% |
+14,080
| New | +$323K |
|
774
Distribution Solutions Group
DSGR
$1.6B
| $331K | 0.01% |
26,266
-7,708
| -23% | -$88.4K |
|
|
LLL
775
DELISTED
L3 Technologies, Inc.
LLL
| $328K | 0.01% |
1,739
-66,100
| -97% | -$11.9M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2017 Portfolio in Review
As of Q3 2017, Jacobs Levy Equity Management held 1,074 positions worth $5.14B, up 10% from $4.68B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jacobs Levy Equity Management deployed $273M of net new capital in Q3 2017, opening 159 new positions and adding to 412 existing holdings. Its largest new stake was Allergan plc: 114,141 shares worth $23.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Intuit, an estimated $26.1M trimmed.
- Jacobs Levy Equity Management's largest Q3 2017 buy was Allergan plc: 114,141 shares worth $23.4M.
- Jacobs Levy Equity Management added most to Philip Morris in Q3 2017, an estimated $28.6M increase.
- Jacobs Levy Equity Management's biggest Q3 2017 reduction was Intuit, cutting an estimated $26.1M.
- Jacobs Levy Equity Management fully exited BWX Technologies in Q3 2017, selling an estimated $13.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 11% of its $5.14B portfolio in Q3 2017.
- Jacobs Levy Equity Management opened 159 new positions and closed 136 in Q3 2017.
- Jacobs Levy Equity Management's portfolio value rose 10% quarter-over-quarter to $5.14B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2017, filed 14 Nov 2017.